Articles

There is no requirement for a medicine to display the country of origin on the label.

New modelling demonstrates that supply of critical medicines for ventilating patients supports a return to elective surgery

Ads for health products are everywhere, but don't believe everything you read

Information updated

In response to the COVID-19 pandemic, the TGA is implementing Serious Shortage Medicine Substitution Notices

Interim statement concerning the use of GS1 Australia's Recall Health platform

This specification describes the minimal acceptable performance and desired features for a ventilator to be used in Australian hospitals during the current SARS-CoV2 outbreak.

The TGA is publishing the latest information about medicines and medical devices as it relates to COVID-19 on this page

Information for cannabis manufacturers regarding TGO 93

The Health Products Regulation Group has published a new regulatory science strategy

Some label warnings no longer required for medicines containing very low concentrations of menthol or methyl salicylate

General information for consumers on prescription opioids

Considering microneedling? Make sure you do your research first

Commonly asked questions about stem cells and regulation

Considering cosmetic injections? Complete this checklist first

Are you aware of the risks associated with cosmetic injections?

Recommended paracetamol doses and labelling rquirements

The TGA will not pursue the development of an alternative quality standard for sunscreen excipient ingredients at this time in 2019.

Information for consumers on the use of performance and image enhancing drugs

Changes will be made to the regulation of nappy rash products on 1 January 2020

New regulations for stem cell treatments in Australia came into force on 1 July 2019

The transition period for updating medicine ingredient names ends on 30 April 2020.

Do your research before consenting to live blood analysis, electrodermal testing and other related tests

Indications proposed by industry during the 2017 public comment period have been published

Australian launch of a new product called Nyxoid nasal spray for opioid overdoses